Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Change in Intangibles (2022 - 2025)

Cytek Biosciences (CTKB) has disclosed Change in Intangibles for 4 consecutive years, with $32000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Intangibles rose 255.56% year-over-year to $32000.0, compared with a TTM value of $106000.0 through Dec 2025, down 48.04%, and an annual FY2025 reading of $106000.0, down 48.04% over the prior year.
  • Change in Intangibles was $32000.0 for Q4 2025 at Cytek Biosciences, up from -$2000.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $148000.0 in Q2 2024 and bottomed at -$8000.0 in Q3 2024.
  • Average Change in Intangibles over 4 years is $46846.2, with a median of $55000.0 recorded in 2023.
  • The sharpest move saw Change in Intangibles crashed 112.7% in 2024, then skyrocketed 255.56% in 2025.
  • Year by year, Change in Intangibles stood at $80000.0 in 2022, then dropped by 23.75% to $61000.0 in 2023, then tumbled by 85.25% to $9000.0 in 2024, then surged by 255.56% to $32000.0 in 2025.
  • Business Quant data shows Change in Intangibles for CTKB at $32000.0 in Q4 2025, -$2000.0 in Q3 2025, and $74000.0 in Q2 2025.